DiscoverScientific American Content: GlobalFor 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]
For 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]

For 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]

Update: 2024-01-30
Share

Description

This year, healthcare providers have tools to help prevent lower respiratory tract disease caused by RSV for older adults. 



This podcast was funded by GSK and produced for GSK by Scientific American Custom Media, a division separate from the magazine’s board of editors.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

For 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]

For 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]

Scientific American Custom Media